An engineered anti-CA19-9 cys-diabody for PET imaging of pancreas cancer and targeting of polymerized liposomal nanoparticles. Background: Anti-angiogenic agents have become the most important class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback